Shares of Semler Scientific Inc. (SMLR), a commercial-stage medical device company, are down over 80% from their 52-week high of $53.38, recorded in February of this year, and trade around $29.
The company's flagship product is QuantaFlo, a patented, FDA-cleared point-of-care product designed to assess arterial blood flow in the extremities swiftly. QuantaFlo supports health care providers in the early diagnosis of peripheral arterial disease, even in patients who are asymptomatic.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.